SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-080180
Filing Date
2010-04-09
Accepted
2010-04-09 11:43:33
Documents
8
Period of Report
2010-05-13
Effectiveness Date
2010-04-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 259473
2 GRAPHIC g86548fsc_logo.jpg GRAPHIC 12125
3 GRAPHIC g86548g01u55.jpg GRAPHIC 6486
4 GRAPHIC g86548g11v32.jpg GRAPHIC 16987
5 GRAPHIC g86548g38g72.jpg GRAPHIC 7189
6 GRAPHIC g86548pc_001.jpg GRAPHIC 148330
7 GRAPHIC g86548pc_002.jpg GRAPHIC 135089
8 GRAPHIC g86548pc_003.jpg GRAPHIC 177774
  Complete submission text file 0001193125-10-080180.txt   956539
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

IRS No.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-20897 | Film No.: 10741524
SIC: 2834 Pharmaceutical Preparations